NCT02463643View on ClinicalTrials.gov

To Evaluate Efficacy and Safety of Z-215 in Erosive Esophagitis

PHASE2CompletedINTERVENTIONAL
Enrollment

503

Participants

Timeline

Start Date

May 31, 2015

Primary Completion Date

October 31, 2016

Study Completion Date

March 31, 2017

Conditions
Esophagitis, Reflux
Interventions
DRUG

Z-215 10mg

Z-215 10mg, capsules

DRUG

Z-215 20mg

Z-215 20mg, capsules

DRUG

Z-215 Placebo

Z-215 placebo-matching capsules

DRUG

Rabeprazole Sodium

Rabeprazole Sodium 10mg tablets

DRUG

Rabeprazole Sodium Placebo

Rabeprazole Sodium Placebo placebo-matching tablets

Trial Locations (1)

Unknown

Tokyo

Sponsors
All Listed Sponsors
lead

Zeria Pharmaceutical

INDUSTRY